VENUS REMEDIES
|
The Current P/E Ratio of VENUS REMEDIES is 11.39.
Share Price | ₹296.2 | Feb 28,2025 |
Market Cap | ₹396.9 Cr | |
Earnings-TTM | ₹34.8 Cr | TTM-Consolidated Results |
Price/Earnings | 11.39x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of VENUS REMEDIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹396.9 Cr] as on Feb 28,2025
(/) Earnings [ ₹34.8 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 11.39x ]
Thus, for VENUS REMEDIES , the investors are currently willing to pay 11.39 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VENUS REMEDIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of VENUS REMEDIES over the last five years.
Historical PE (Price/Earnings) ratio chart of VENUS REMEDIES
PE Ratio Performance Analysis for VENUS REMEDIES
- VENUS REMEDIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 7.55x.
- VENUS REMEDIES 's operated at median p/e ratio of 8.15x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VENUS REMEDIES 's p/e ratio peaked in Mar2024 at 15.31x.
- VENUS REMEDIES 's p/e ratio hit its five-year low in Mar2020 of 0x.
How does VENUS REMEDIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
VENUS REMEDIES | 34.84 | 11.39 | 396.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 33.30 | 382,430.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 70.35 | 145,410.0 |
CIPLA LTD | 5,000.43 | 22.79 | 113,950.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 53.54 | 99,682.3 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 17.18 | 93,261.6 |
MANKIND PHARMA LTD | 2,050.73 | 46.07 | 94,482.5 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.20 | 88,166.2 |
LUPIN LTD | 2,892.10 | 30.09 | 87,025.8 |
AUROBINDO PHARMA LTD | 3,500.25 | 17.55 | 61,445.9 |
ABBOTT INDIA LTD | 1,334.46 | 48.52 | 64,747.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VENUS REMEDIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 11.39x |
Max industry PE | 70.35x |
Median industry PE | 30.09x |
Average industry PE | 33.63x |
You may also like the below Video Courses